Clarity Pharmaceuticals Ltd. (CU6) Income Statement
120 Followers
Clarity Pharmaceuticals Ltd. Income Statement
Last quarter (Q4 2022), Clarity Pharmaceuticals Ltd.'s total revenue was AU$―. In Q4, Clarity Pharmaceuticals Ltd.'s net income was AU$―. See Clarity Pharmaceuticals Ltd.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Jun 22
Total Revenue
-
Cost of Revenue
-
Gross Profit
-
Operating Expense
AU$ 30.29M
Operating Income
AU$ -30.29M
Net Non Operating Interest Income Expense
AU$ 95.09K
Other Income Expense
AU$ 6.46M
Pretax Income
AU$ -23.74M
Tax Provision
AU$ 17.63K
Earnings From Equity Interest Net Of Tax
-
Net Income Common Stockholders
AU$ -23.75M
Basic EPS
AU$ -0.10
Diluted EPS
AU$ -0.10
Basic Average Shares
AU$ 247.70M
Diluted Average Shares
AU$ 247.70M
Dividend Per Share
-
Total Operating Income As Reported
-
Reported Normalized Basic E P S
-
Reported Normalized Diluted E P S
-
Rent Expense Supplemental
-
Total Expenses
-
Net Income From Continuing And Discontinued Operation
AU$ -23.75M
Normalized Income
AU$ -23.75M
Interest Expense
-
EBIT
AU$ -30.29M
EBITDA
AU$ -30.24M
Currency in AUD
Clarity Pharmaceuticals Ltd. Earnings and Revenue History